Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Novel approach to amoebic gill disease in salmon could benefit humans
Amoebic gill disease is a major disease of farmed Atlantic salmon.

Scientists to repurpose drugs used to treat human parasitic diseases.

Researchers at the University of Glasgow are developing a novel approach to the treatment of amoebic gill disease that could drive down the cost of drugs currently used to treat parasitic diseases in humans.

Caused by the parasite Neoparamoeba perurans, amoebic gill disease (AGD) is major disease of farmed Atrlantic salmon, resulting in severe economic losses across the world. The parasite causes proliferative gill disease, with symptoms including increased mucus on the gills, swollen tissue and breathing difficulties.

In the study, scientists propose to repurpose drugs used to treat human parasitic diseases, such as sleeping sickness, Chagas disease and leishmaniasis, to manage AGD in Atlantic salmon.

Using the University's 'drug discovery pipeline', researchers propose to test the potency of these drugs against Neoparamoeba perurans. The team will then test a candidate drug for activity against ADG in Atlantic salmon at a marine trial site in Ireland.

Researchers hope that by opening new markets for these drugs, it will drive down the cost of parasitic treatment in humans, particularly in the developing world where unaffordable healthcare can lead to millions of unnecessary deaths.

Study co-author Dr Martin Llewellyn, said: “This project is a great opportunity to understand some of the science behind symbiosis, develop a much-needed drug for salmon aquaculture and also hopefully have a beneficial impact on the treatment of diseases that impact the lives of hundreds of millions of people in the tropics.”

Funded by the BBSRC, the project will involve a collaboration with the Marine Institute, Ireland and Dalhousie University, Canada.

Become a member or log in to add this story to your CPD history

RCVS launches photo contest for Mental Health Awareness Week

News Story 1
 The RCVS Mind Matters Initiative (MMI) is holding a photo competition for Mental Health Awareness Week to highlight the link between the natural world and wellbeing.

Mental Health Awareness Week (10-16 May) aims to encourage people to talk about their mental health and reduce the stigma that can prevent people from seeking help. This year's theme is nature - notably the connection between the natural world and better mental health.

The RCVS is calling on aspiring photographers to submit a photo on this theme to Lisa Quigley, Mind Matters manager, at l.quigley@rcvs.org.uk with a short explanation about their submission and why nature improves their mental health and wellbeing.  

Click here for more...
News Shorts
WSAVA to host free webinar on illegal online puppy trade

The World Small Animal Veterinary Association (WSAVA) has announced a free webinar to update veterinary professionals across Europe about the illegal online puppy trade. Taking place on Tuesday, 25 May, the webinar will also discuss the importance of the new EU Animal Health Law to help prevent illegal pet sales and make sellers accountable for their actions.

WSAVA chair Dr Natasha Lee said: "Veterinary professionals regularly have to deal with the repercussions of illicit breeding and trading when presented with clinically ill and sometimes dying puppies and distraught owners. Our webinar will equip veterinarians in Europe with the knowledge to play their part in upholding the new legislation and to contribute to new solutions for regulating the online puppy trade."

For more details visit wsava.org